#drug-trials

[ follow ]

Amazing' trial shows drug combination stops lung cancer advancing for longer

A new drug combination significantly extends progression-free survival in advanced lung cancer patients compared to standard treatment.

An obesity pill study tested on just 25 patients led to a stunning $16.8 billion increase in Swiss drugmaker Roche's market value

Positive results in small trials for obesity drugs led to significant market value gains, driven by the large potential market size.
[ Load more ]